Literature DB >> 23462132

Ustekinumab for moderate-to-severe Crohn's disease.

Gauree Gupta Konijeti1, Andrew T Chan.   

Abstract

Entities:  

Year:  2013        PMID: 23462132     DOI: 10.1053/j.gastro.2013.02.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  1 in total

Review 1.  Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.

Authors:  Ersilia M DeFilippis; Randy Longman; Michael Harbus; Kyle Dannenberg; Ellen J Scherl
Journal:  Curr Gastroenterol Rep       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.